WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2005123738) PYRRAZOLO-PYRIMIDINE DERIVATIVES
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2005/123738    International Application No.:    PCT/EP2005/006302
Publication Date: 29.12.2005 International Filing Date: 13.06.2005
Chapter 2 Demand Filed:    23.12.2005    
IPC:
C07D 487/04 (2006.01), A61K 31/519 (2006.01), A61P 25/00 (2006.01)
Applicants: F.HOFFMANN-LA ROCHE AG [CH/CH]; Grenzacherstr. 124, CH-4070 Basel (CH) (For All Designated States Except US).
GOETSCHI, Erwin [CH/CH]; (CH) (For US Only).
WICHMANN, Juergen [DE/DE]; (DE) (For US Only).
WOLTERING, Thomas, Johannes [DE/DE]; (DE) (For US Only)
Inventors: GOETSCHI, Erwin; (CH).
WICHMANN, Juergen; (DE).
WOLTERING, Thomas, Johannes; (DE)
Agent: BRAUN, Axel; Grenzacherstrasse 124, CH-4070 Basel (CH).
POPPE, Regina; 124 Grenzacherstrasse, CH-4070 Basel (CH)
Priority Data:
04102837.4 21.06.2004 EP
Title (EN) PYRRAZOLO-PYRIMIDINE DERIVATIVES
(FR) DERIVES DE PYRRAZOLO-PYRIMIDINE
Abstract: front page image
(EN)The invention relates to compounds of formula (I) wherein R1, R2, R3, R4, R5 and p are as defined in the description and claims as well as to pharmaceutically acceptable salts thereof per se and as pharmaceutically active substances, their manufacture, medicaments based on a compound in accordance with the invention and their production, as well as the use of the compounds in accordance with the invention in the control or prevention of illnesses of the aforementioned kind, and, respectively, for the production of corresponding medicaments.
(FR)L'invention concerne des composés représentés par la formule (I) dans laquelle R1, R2, R3, R4 et R5 correspondent aux définitions de la description et des revendications, ainsi que des sels pharmaceutiquement acceptables de ceux-ci en tant que tels, la préparation de ces composés, et des compositions pharmaceutiques formées avec ces composés, ainsi que la production de ces dernières, de même que l'utilisation de ces composés pour la suppression ou la prévention des maladies mentionnées, et la production des médicaments correspondants.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)